Skip to content

Clinical Study of TCM Aromatherapy to Improve Tumor-Related Depression in Breast Cancer Patients During Chemotherapy

Clinical Study of TCM Aromatherapy to Improve Tumor-Related Depression in Breast Cancer Patients During Chemotherapy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088693
Enrollment
Unknown
Registered
2024-08-25
Start date
2023-04-03
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Control group:The patient was given placebo inhalation therapy, and the patient was given a mask aromatherapy buckle and a placebo (sunflower oil), instructed to drop a drop of sunflower oil on the co
Essential oil group:The essential oil group was given Sanhua essential oil inhalation therapy every day, and the patients were given mask aromatherapy buckles and Sanhua essential oil, and instructed

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Female, aged = 18 years old and = 70 years old; (2) Meet the diagnostic criteria for breast cancer; (3) Meet the diagnostic criteria for tumor-related depression; (4) Mild and moderate depression (5) Currently in the adjuvant chemotherapy stage, and it is expected that there will be no chemotherapy regimen change during the development of this study; (6) Understand, agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Moderate-to-severe depression (PHQ-9=15 points); (2) Patients with severe circulatory, respiratory, digestive, blood, urinary, nervous, and endocrine system diseases, such as acute myocardial infarction, heart failure, renal insufficiency, acute cerebral infarction, lupus erythematosus, etc., and the investigator believes that other systemic diseases of the patient will affect the results of this study; (3) Patients with other severe psychiatric symptoms other than depression or previous mental disorders and positive family history; (4) Those who have participated in other clinical studies or similar types of researchers in the past month; (5) Patients who are allergic to essential oils involved in this study; (6) People with a history of allergic rhinitis and allergic asthma, and impaired sense of smell; (7) Those who have taken anti-anxiety and depression and sleep-improving drugs in the past two weeks; (8) Women who have a plan to get pregnant and are pregnant.

Design outcomes

Primary

MeasureTime frame
Total effective rate in HAMD-24 ;HAMD-24 total score;

Secondary

MeasureTime frame
TCM syndrome scoring points;Pittsburgh sleep quality index;Incidence of nausea and vomiting;Functional magnetic resonance;

Countries

China

Contacts

Public ContactLi Xiaofei; Jiang Ke

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of

765644772@qq.com+86 183 3720 0609

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026